- Product NDC
- 15370-250
- 11-digit product format
- 153700250
- Labeler code
- 15370
- Product ID
- 15370-250_4889480e-2d59-4dbd-a808-ea7fce24f922
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL ACETATE, D-, THIAMINE HYDROCHLORIDE, RIBOFLAVIN, NIACIN, PYRIDOXINE HYDROCHLORIDE, LEVOMEFOLATE MAGNESIUM, FOLIC ACID, CYANOCOBALAMIN, IRON PENTACARBONYL, POTASSIUM IODIDE, MAGNESIUM OXIDE, DOCONEXENT, and ICOSAPENT
- Dosage form
- CAPSULE, LIQUID FILLED
- Route
- ORAL
- Labeler
- CarWin Pharmaceutical Associates, LLC
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketing start
- 2015-06-01
- Substance
- .ALPHA.-TOCOPHEROL ACETATE, D-; ASCORBIC ACID; CHOLECALCIFEROL; CYANOCOBALAMIN; DOCONEXENT; FOLIC ACID; ICOSAPENT; IRON PENTACARBONYL; LEVOMEFOLATE MAGNESIUM; MAGNESIUM OXIDE; NIACIN; POTASSIUM IODIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; THIAMINE HYDROCHLORIDE
- Active strength
- 15; 55; 1000; 14; 200; 400; 15; 31; 600; 30; 5; 200; 35; 1.8; 1.3 [iU]/1; mg/1; [iU]/1; ug/1; mg/1; ug/1; mg/1; mg/1; ug/1; mg/1; mg/1; ug/1; mg/1; mg/1; mg/1
- Pharmacologic classes
- Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Calculi Dissolution Agent [EPC], Folate Analog [EPC], Folic Acid [CS], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Nicotinic Acid [EPC], Nicotinic Acids [CS], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes